Advisory Services for
Company Sale and Divestiture

Are you interested in selling a healthcare company?

ConAlliance is the expert in healthcare mergers and acquisitions.

Do you plan to sell your medical device company?

We are a longstanding leader in advising on the “sell side” of healthcare M&A transactions.

in case of divestiture life science company ConAlliance Investment Banking is the recommended advisor.

Three general forms can be used for the acquisition of a business: (1) a purchase
of the assets of the business, (2) a purchase of the stock of the target
owning the assets, and (3) a statutory merger of the buyer (or an affiliate) with
the target. It is possible to combine several forms so that, for example, some
assets of the business are purchased separately from the stock of the company
that owns the rest of the assets, and a merger occurs immediately thereafter.

company sales Pharmaceuticals and drugs

With a proven track record of life science transaction services, on the buy-side and sell-side, ConAlliance has served the European healthcare industry as a specialized investment banking and consulting firm. With outstanding healthcare M&A experience, we are engaged by public and private organizations to sell or divest a business or product line or to conduct comprehensive acquisition searches to help our clients grow by a corporate M&A transaction.

Transaction services, medical devices, m&a, germany

m&a labs laboratories diagnostic company germany

Linde AG a German supplier of industrial gas, said Sunday it plans to acquire Lincare Holdings Inc., a U.S. provider of respiratory therapy, oxygen and other services to patients at home, for about $4.6 billion. Industrial-gas suppliers have been expanding into the growing business of providing services and equipment such as ventilators or oxygen tanks to people with asthma and other diseases who are managing their conditions at home. Lincare, based in Clearwater, Fla., has more than 800,000 customers in 48 states and Canada, according to its website. In a statement, Munich-based Linde said it had submitted a cash offer of $41.50 per common share to acquire Lincare.

divestiture hospital life sciences

M&A consultants healthcare germany

you might be intersted in the following topics:

• M&A advisory services
• m&a healthcare
• mergers & acquisitions healthcare
• mergers and acquisitions life science
• mergers acquisitions medical devices
• pharmaceuticals & biotechnology mergers & acquisitions, M&A
• healthcare investment banking
• mergers & acquisitions wound care m&a

M&A consultants healthcare UK

In mergers & Acquisitions and (commercial) due diligence services we deliver outstanding impact on the reputation and success of our clients, in the UK and globally. In pursuing this we contribute to a sustainable and prosperous society.

ConAlliance assits you, when you plan to

• divestiture healthcare company,
• divestiture medical device company, or
• acquire healthcare company